Fully Automated Anesthesia, Analgesia and Fluid Management

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
General Anesthetic Drug OverdoseAdverse Effect of Intravenous Anesthetics, SequelaComplication of AnesthesiaDrug Delivery System MalfunctionHemodynamic InstabilityUnderdosing of Other General Anesthetics
Interventions
OTHER

BIS XP, Covidien, Ireland

Closed loop for propofol and remifentanil using BIS XP TM, Covidien, Ireland

OTHER

EV-1000 TM, Edwards Lifesciences, Irvine, California, USA

Closed loop for fluid perfusion using EV-1000 TM, Edwards Lifesciences, Irvine, CA, USA

Trial Locations (1)

1070

Erasme University Hospital, Brussels

All Listed Sponsors
collaborator

Hopital Foch

OTHER

lead

Erasme University Hospital

OTHER

NCT02886806 - Fully Automated Anesthesia, Analgesia and Fluid Management | Biotech Hunter | Biotech Hunter